Certified by Founder Lodge
Action Potential Venture Capital
United States - Palo Alto, CA
INVESTOR
1 Disclosed Funding Rounds $150,000,000
4 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Action Potential Venture Capital (APVC) is GSK's bioelectronic medicines venture fund. APVC is focused on the next generation of peripheral neuromodulation medical devices, and invests in co
| Company | Date | Round | Raised |
|---|---|---|---|
 Saluda Medical |
April, 17 ,2023 | Unknown | $150,000,000 |
 Presidio Medical, Inc. |
June, 27 ,2023 | Series C | $72,000,000 |
 Neuspera Medical Inc. |
July, 16 ,2024 | Series D | $23,000,000 |
 MicroTransponder |
March, 18 ,2025 | Series F | $65,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
